Health Canada Approves Dexcom G7 15 Day Continuous Glucose Monitoring System

Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System for adults with diabetes, extending the sensor wear time to 15.5 days. This approval aims to enhance convenience for patients, reduce sensor waste, and deepen digital health integration in diabetes management. The system boasts high accuracy and integrated app-based data sharing.